Navigation Links
Array BioPharma Provides Updates On Clinical Data At The 2012 American Society Of Hematology Meeting
Date:12/10/2012

methasone in patients with relapsed or refractory MM.
  • Phase 1b investigator-sponsored trial in combination with Kyprolis in patients with relapsed or refractory MM who are refractory or intolerant to Velcade therapy. 
  • In the Phase 1 trial with ARRY-614, a dual p38/Tie2 inhibitor, the new formulation demonstrated improved bioavailability and inter-patient variability in our ongoing study of low or intermediate-1 risk Myelodysplastic Syndromes (MDS).  With this new formulation, peak plasma concentrations and overall exposures are higher than with the original formulation, possibly affording more extensive Tie2 inhibition. The ongoing Phase 1 dose escalation trial of the optimized ARRY-614 formulation may further our understanding of the contributions of these targets to the pathogenesis of MDS.  In our prior study in a similar population, we observed a 38% response rate for hematologic improvement in patients receiving the highest dose of the prior formulation. At this dose, ARRY-614 demonstrated multilineage hematologic improvement in 67% of the responders, improving two or more cytopenias (neutropenia, thrombocytopenia and/or anemia).  The most common drug related adverse events in this study included diarrhea and skin rash.

    After the presentations, the posters and presentation slides will be available to view and download in PDF format on Array's website at www.arraybiopharma.com.  ASH is the world's largest professional society concerned with the causes and treatments of blood disorders, and presentation of clinical trial results at the annual conference marks an important strategic milestone in the continued development of these two drugs.

    About Array BioPharma

    Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small‑molecule drugs to treat patients afflict
    '/>"/>

    SOURCE Array Biopharma
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related biology technology :

    1. Array BioPharma Announces Exercise And Closing Of Underwriters Over-Allotment Option
    2. John A. Orwin Joins Array BioPharma Board Of Directors
    3. Array BioPharma To Present Clinical Data At The 2012 ASH Meeting On ARRY-520, A KSP Inhibitor, And ARRY-614, A Dual p38/Tie2 Inhibitor
    4. Array BioPharma to Hold Conference Call on Monday, November 5, 2012 to Discuss Submitted ASH Abstracts
    5. Solar nanowire array may increase percentage of suns frequencies available for energy conversion
    6. RayBiotech, Inc. and the University of Oslo Enter into Antibody Array Services Collaboration
    7. Phalanx Biotech Group Announces CytoOneArray®, a Targeted Chromosomal Microarray
    8. Self-assembling nanorods: Berkeley Lab researchers obtain 1-, 2- and 3-D nanorod arrays and networks
    9. Maine Manufacturing, LLC Announces Global Distribution of FAST® Protein Array Products
    10. Quanterix Develops Microfluidic Consumable That Will Enable Next Generation Molecular Diagnostic Systems based on Single Molecule Array Technology
    11. TransCelerate BioPharma Inc. Appoints Dalvir Gill as Chief Executive Officer
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/19/2014)... EVANSTON, Ill. , Dec. 19, 2014 ... to develop novel drugs for diseases of the central ... Ph.D., president and chief executive officer, will present at ... Dr. Riedel,s presentation will take place at 3:00 p.m. ... St. Francis in San Francisco, Calif. ...
    (Date:12/19/2014)... 2014 Research and Markets ( ... "Technology Innovations in Smart Fabrics (Technical Insights)" ... http://photos.prnewswire.com/prnh/20130307/600769 The Research ... a detailed assessment on technological advancements and market ... 1. The Smart Fabrics market is ...
    (Date:12/19/2014)... Ed Bilsky, Ph.D., vice president for Research and ... the Neurosciences (CEN), and professor of pharmacology at the ... member of the prestigious Dana Alliance for Brain Initiatives ... receive this honor. , The Dana Alliance ... Foundation. Its mission is to advance public education ...
    (Date:12/19/2014)... The empty capsules market is experiencing growth primarily ... innovations in the empty capsules market. The fast-growing ... of the empty capsules market. , Get Full ... Report , The report will enrich both established ... gauge the pulse of the market which in ...
    Breaking Biology Technology:Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2Technology Innovations in Smart Fabrics (Technical Insights) 2UNE's Ed Bilsky Named Member of Dana Alliance for Brain Initiatives 2UNE's Ed Bilsky Named Member of Dana Alliance for Brain Initiatives 3Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 3Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 4
    ... June 10, 2011 PharmaNet Development Group, Inc. (the "Company" ... tender offer and consent solicitation (the "Offer") for any and ... 2017 (the "Notes"), it has elected to extend the consent ... City time, on June 10, 2011, unless extended or earlier ...
    ... Professor of Mechanical Engineering at Stevens Institute of ... Specialist Roster as a candidate for grants to ... US Department of State, the Fulbright Specialist Program ... global collaborations that strengthen the positions of US ...
    ... 2011 The David H. Murdock Research Institute (DHMRI) ... Inc. (ITI) as a next step in the continued ... Research Campus in Kannapolis, NC. Driven by a mission ... for the range of immune-related diseases, the DHMRI provides ...
    Cached Biology Technology:PharmaNet Extends Consent Payment Deadline for Notes Tendered in Its Tender Offer and Consent Solicitation 2PharmaNet Extends Consent Payment Deadline for Notes Tendered in Its Tender Offer and Consent Solicitation 3PharmaNet Extends Consent Payment Deadline for Notes Tendered in Its Tender Offer and Consent Solicitation 4Dr. Frank Fisher of Stevens selected for Fulbright specialist roster 2David H. Murdock Research Institute Assumes Control of the Immune Tolerance Institute and Establishes a State of the Art Human Immune Monitoring Laboratory for Biomarker Discovery and Development 2David H. Murdock Research Institute Assumes Control of the Immune Tolerance Institute and Establishes a State of the Art Human Immune Monitoring Laboratory for Biomarker Discovery and Development 3
    (Date:12/10/2014)...     Jifflenow ...   Jifflenow, a leading provider ... business-to-business (B2B) events, today announced a partnership with ... communication (NFC), Bluetooth low energy (BLE), and cloud-based ... Jifflenow will integrate its meeting scheduling ...
    (Date:12/3/2014)... Ariz. , Dec. 2, 2014 As ... hand readers, Inception Technologies is pleased to announce the ... easier for customers to collect the workforce data that ... problems that have been left by existing readers. Many ... user interface, connectivity and modern technology. Older models force ...
    (Date:11/21/2014)... , Nov. 20, 2014   Atmel® Corporation ... in microcontroller (MCU) and touch technology solutions, today launched ... sensors with the widest V cc range ... temperature accuracy and faster I 2 C bus communication ... serial EEPROM memory making them ideal for consumer, industrial, ...
    Breaking Biology News(10 mins):Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3Inception Technologies to Release New Biometric Reader 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4
    ... running out of room to maneuver. As forests in ... human uses, populations of these arboreal leaf eaters, which depend ... isolated and at risk. But one type of sustainable agriculture, ... critical refuges and bridges between intact forests for the iconic ...
    ... lives in increasingly humanised landscapes, with limited food resources ... to Spanish researchers, food availability plays a secondary role ... allow wolves to remain in human-dominated environments in Galicia. ... lupus signatus ) varies greatly across the Iberian Peninsula ...
    ... July 11, 2012 Researchers at the Translational Genomics Research ... could lead to a less costly, less invasive and more ... CKD is a major complication of diabetes, high blood pressure ... is characterized by a progressive deterioration of the kidney,s ability ...
    Cached Biology News:Down on the cacao farm: Sloths thrive at chocolate's source 2Down on the cacao farm: Sloths thrive at chocolate's source 3The Iberian wolf lives close to humans more for refuge than for prey 2TGen method isolates biospecimens for treatment of kidney disease 2
    ... Intended for users requiring mass ... AXIMA-LNR linear MALDI TOF Mass spectrometer ... QA/QC applications and for high performance ... oligonucleotide QA/QC, SNP analysis, protein detection, ...
    Rat Lung Fibroblasts (RLF) (>500,000 cells)...
    ... DNA is an ideal small concentrator for ... capable of removing water and organic solvents ... tubes, microplates, vials and round bottom flasks. ... the busy lab. ,The built-in special runs ...
    ... miVac Duo is suitable for use with ... organic solvents through to water and some ... centrifugal concentrator capable of removing water and ... formats including tubes, microplates, vials and round ...
    Biology Products: